150 related articles for article (PubMed ID: 17330792)
1. Blood group AB is associated with increased risk for severe dengue disease in secondary infections.
Kalayanarooj S; Gibbons RV; Vaughn D; Green S; Nisalak A; Jarman RG; Mammen MP; Perng GC
J Infect Dis; 2007 Apr; 195(7):1014-7. PubMed ID: 17330792
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
[TBL] [Abstract][Full Text] [Related]
3. Severe dengue virus infection in travelers: risk factors and laboratory indicators.
Wichmann O; Gascon J; Schunk M; Puente S; Siikamaki H; Gjørup I; Lopez-Velez R; Clerinx J; Peyerl-Hoffmann G; Sundøy A; Genton B; Kern P; Calleri G; de Górgolas M; Mühlberger N; Jelinek T;
J Infect Dis; 2007 Apr; 195(8):1089-96. PubMed ID: 17357044
[TBL] [Abstract][Full Text] [Related]
4. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic.
Thomas L; Verlaeten O; Cabié A; Kaidomar S; Moravie V; Martial J; Najioullah F; Plumelle Y; Fonteau C; Dussart P; Césaire R
Am J Trop Med Hyg; 2008 Jun; 78(6):990-8. PubMed ID: 18541782
[TBL] [Abstract][Full Text] [Related]
5. Household survey of dengue infection in central Brazil: spatial point pattern analysis and risk factors assessment.
Siqueira JB; Martelli CM; Maciel IJ; Oliveira RM; Ribeiro MG; Amorim FP; Moreira BC; Cardoso DD; Souza WV; Andrade AL
Am J Trop Med Hyg; 2004 Nov; 71(5):646-51. PubMed ID: 15569799
[TBL] [Abstract][Full Text] [Related]
6. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.
Laoprasopwattana K; Libraty DH; Endy TP; Nisalak A; Chunsuttiwat S; Vaughn DW; Reed G; Ennis FA; Rothman AL; Green S
J Infect Dis; 2005 Aug; 192(3):510-9. PubMed ID: 15995967
[TBL] [Abstract][Full Text] [Related]
7. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
8. Is dengue severity related to nutritional status?
Kalayanarooj S; Nimmannitya S
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):378-84. PubMed ID: 15916044
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia.
Khan NA; Azhar EI; El-Fiky S; Madani HH; Abuljadial MA; Ashshi AM; Turkistani AM; Hamouh EA
Acta Trop; 2008 Jan; 105(1):39-44. PubMed ID: 17983609
[TBL] [Abstract][Full Text] [Related]
10. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.
Vazquez S; Acosta N; Ruiz D; Calzada N; Alvarez AM; Guzman MG
J Virol Methods; 2009 Jul; 159(1):6-9. PubMed ID: 19442837
[TBL] [Abstract][Full Text] [Related]
12. First case of Dengue virus infection in Nepal.
Pandey BD; Rai SK; Morita K; Kurane I
Nepal Med Coll J; 2004 Dec; 6(2):157-9. PubMed ID: 16295753
[TBL] [Abstract][Full Text] [Related]
13. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype.
Acioli-Santos B; Segat L; Dhalia R; Brito CA; Braga-Neto UM; Marques ET; Crovella S
Hum Immunol; 2008 Feb; 69(2):122-8. PubMed ID: 18361938
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a dengue patient cohort in Recife, Brazil.
Cordeiro MT; Silva AM; Brito CA; Nascimento EJ; Magalhães MC; Guimarães GF; Lucena-Silva N; de Carvalho EM; Marques ET
Am J Trop Med Hyg; 2007 Dec; 77(6):1128-34. PubMed ID: 18165535
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection.
de Souza VA; Tateno AF; Oliveira RR; Domingues RB; Araújo ES; Kuster GW; Pannuti CS
J Clin Virol; 2007 Jul; 39(3):230-3. PubMed ID: 17509934
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and risk factors of ocular complications following dengue infection.
Seet RC; Quek AM; Lim EC
J Clin Virol; 2007 Feb; 38(2):101-5. PubMed ID: 17142099
[TBL] [Abstract][Full Text] [Related]
17. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
18. Antibodies determine virulence in dengue.
Halstead SB
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E48-56. PubMed ID: 19751402
[TBL] [Abstract][Full Text] [Related]
19. Neurologic dengue manifestations associated with intrathecal specific immune response.
Puccioni-Sohler M; Soares CN; Papaiz-Alvarenga R; Castro MJ; Faria LC; Peralta JM
Neurology; 2009 Oct; 73(17):1413-7. PubMed ID: 19858464
[TBL] [Abstract][Full Text] [Related]
20. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis.
Myint KS; Endy TP; Mongkolsirichaikul D; Manomuth C; Kalayanarooj S; Vaughn DW; Nisalak A; Green S; Rothman AL; Ennis FA; Libraty DH
J Infect Dis; 2006 Sep; 194(5):600-7. PubMed ID: 16897658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
